Phase I-II

Alzheimer’s research data questioned by Department of Justice

09-Aug-2022 By Jenni Spinner

After scientists and reporters raised red flags about a study, Cassava Sciences is being accused of falsifying data in pursuit of an Alzheimer’s treatment.

MCI OneHealth, MDClone team up to use synthetic data to accelerate research

09-Aug-2022 By Nick Taylor

The two companies are collaborating to generate subject data sets designed to help users find insights that can speed up research and improve patient care.

Pfizer to acquire sickle cell disease specialist for $5.4b USD

08-Aug-2022 By Jenni Spinner

Biopharmaceutical company Global Blood Therapeutics specializes in conditions that often disproportionately impact underrepresented communities, such as SCD.

People on the Move: August 2022

04-Aug-2022 By Jenni Spinner

This month’s announcements of appointments, partnerships, expansions, and mergers include Curia, Thread, TFF Pharmaceuticals, and other notable companies.

Medical specialty societies can benefit from regulatory progress: IQVIA

04-Aug-2022 By Jenni Spinner

An expert from the trial tech firm explains how the 21st Century Cures Act and other recent regulatory advancements can elevate clinical data registries.

Boehringer, Seqster ink 3-year health data deal to accelerate research

04-Aug-2022 By Nick Taylor

The pharmaceutical company has forged a partnership with the life-sciences tech firm in an effort to elevate data collection and speed up clinical studies.

Bilingual staff boost Spanish speaker interest in trials: study

02-Aug-2022 By Nick Taylor

A survey by SubjectWell indicates that having Spanish-speaking research personnel increases interest in trial participation among Latino potential patients.

GCP update: advice on what to expect and how to prepare

01-Aug-2022 By Jenni Spinner

With updates to the Guideline for Good Clinical Practice Advancements on the horizon, an industry expert offers some perspective on what might be ahead.

Curavit, Swing team up on fibromyalgia therapeutic trial

01-Aug-2022 By Nick Taylor

The CRO and DTx specialist are joining forces to conduct a hybrid clinical trial of a potential digital therapeutic that is aimed at treating fibromyalgia.

Investment in decentralized clinical trials pays off: analysis

28-Jul-2022 By Jenni Spinner

A joint study conducted by analysts from Medable and the Center for the Study of Drug Development points toward shorter cycle times, cost savings, and more.

Incorporating patient voice elevates rare-disease trials: Casimir

28-Jul-2022 By Jenni Spinner

During the World Orphan Drug Congress, a co-founder of the CRO outlined how patient perspective can be vital to better results in rare-disease research.

Art contest aims to build awareness of clinical trial opportunities

26-Jul-2022 By Jenni Spinner

Bridging the Gap for Clinical Trials is a free competition designed to employ artistic expression to dispel misinformation start positive conversations.

Cancer Moonshot meeting brings together survivors, industry leaders

26-Jul-2022 By Jenni Spinner

The gathering, convened by patient advocacy group Fight Colorectal Cancer, responded to President Biden’s call to improve screening and treatment options.

Human element important for decentralized trial advancement

25-Jul-2022 By Jenni Spinner

During the Decentralized Trial Technology event, experts from CVS Health, University of Chicago, and ACRP shared insight on what can increase DCT success.

Incorporating patient preference vital to study success: ICON

25-Jul-2022 By Jenni Spinner

A leader from the CRO discusses how capturing the perspective of trial participants can help ensure development of treatments that meet the patients’ needs.

Tech Innovations: July 2022

21-Jul-2022 By Jenni Spinner

This month’s announcements on new products, tech partnerships, and more includes DiMe, Evonik, Advarra, Curebase, ObvioHealth, and other notable companies.

Clene links ALS prospect to improved survival in open-label study

21-Jul-2022 By Nick Taylor

The biotechnology company has reported its candidate for treating amyotrophic lateral sclerosis patients has shown promising results in an early-phase study.

Yale, Vanderbilt, Morehouse join to increase trial diversity

21-Jul-2022 By Jenni Spinner

The research institutions are joining on a community-based collaborative initiative to work toward greater study inclusion, supported by funding from PhRMA.

Collaboration sets sights on acceleration of cystic fibrosis research

20-Jul-2022 By Jenni Spinner

Epistemic AI, Cincinnati Children’s Hospital Medical Center, and Boomer Esiason Foundation are working together to advance research into the rare disease.

Worldwide Clinical Trials, Invitae join to accelerate rare-disease studies

19-Jul-2022 By Jenni Spinner

The CRO and medical genetics company will collaborate to accelerate trials centered on rare diseases, using real-world data and genetic testing technology.

Patient advocacy foundation holds listening session with FDA

19-Jul-2022 By Jenni Spinner

The Foundation for Sarcoidosis Research hosted more than 50 agency leaders in a session that addressed patient concerns in research, care, and diagnosis.

Patient voice, empathy key to pediatric study design: ICON

18-Jul-2022 By Jenni Spinner

A pediatric clinical trial expert from the CRO discusses the unique challenges involved in designing a study when the patients involved are little ones.

Online event centers on decentralized study solutions

18-Jul-2022 By Jenni Spinner

Taking place July 20, the Decentralized Trial Technology webinar will share insights and experiences from a group of knowledgeable virtual trial experts.

Recruitment tool pairs pharma firms with providers to boost patient connection

15-Jul-2022 By Jenni Spinner

Clinical Trial Navigator, from AmerisourceBergen, is designed to help sponsors pair with oncology practices to boost patient recruitment opportunities.

False alarms thwart remote patient monitoring early warnings

15-Jul-2022 By Nick Taylor

A study out of Israel's Sheba Medical Center found wearables used to monitor patients can provide early warnings of deterioration, as well as false alarms.

Lymphoma Research Foundation awards $5.7m to pursue blood cancer treatments

12-Jul-2022 By Jenni Spinner

The organization has given 29 research grants to scientists representing 17 different US institutions pursuing lymphoma treatments and cures in their work.

Precision medicine advancements good news for drug development

12-Jul-2022 By Jenni Spinner

A leader from healthcare commercial intelligence company Definitive Healthcare discusses the rise of precision medicine and the benefits the field can yield.

Tech advances making decentralized trial growth possible: ICON

11-Jul-2022 By Jenni Spinner

In this second of a two-part series, a leader from the CRO discusses the types of technologies supporting DCTs and what might lie on the horizon for the field.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Sema4, Avera Health partner on precision cancer care initiative

07-Jul-2022 By Jenni Spinner

The health care system and analytics company are joining on the ASAP study, a program that constitutes a five-year commitment to advancing cancer solutions.

Phesi analysis highlights extent of cancer trial inclusion issues

07-Jul-2022 By Jenni Spinner

The latest indepth report from the AI-centric analytics provider reveals nearly half of US cancer clinical studies enroll no Latino patient participants.

Decentralized clinical trial transformations are ‘here to stay’: ICON

06-Jul-2022 By Jenni Spinner

In this first of a two-part series, an expert discusses various factors behind the DCT format’s rapid rise and likely longevity in the drug development arena.

Indiana University Health enlists LifeOmic platform for cancer research

06-Jul-2022 By Jenni Spinner

The academic research center has adopted the life science technology company’s cloud-based platform for cancer research, drug discovery, and clinical trials.

Decentralized trial technology center stage at online event

05-Jul-2022 By Jenni Spinner

On July 20, a collection of noted industry experts will lead a lively discussion on the rapid evolution of DCTs, and what advances might be on the horizon.

EHR app taps into remote patient monitoring technology

05-Jul-2022 By Jenni Spinner

Electronic health record solutions provider Athenahealth has partnered with Withings Health Solutions to put the RPM tech into place for clinical and care use.

AstraZeneca to buy blood cancer focused biotech in deal valued at up to $1.27bn

05-Jul-2022 By Jane Byrne

AstraZeneca is to acquire US-based blood cancer specialist, TeneoTwo, in a deal worth around US$1.27bn.

Note from the editor: Small but important changes ahead

30-Jun-2022 By Jenni Spinner

The past two years have been full of shifts and shakes in the drug development field, but the change at Outsourcing-Pharma is easy and one for the better.

Lilly enlists Sidekick for breast cancer digital therapeutic

30-Jun-2022 By Nick Taylor

The pharmaceutical firm will work with the health tech company to create a digital therapeutic intended for patients dealing with a breast cancer diagnosis.

Novartis offers $17.7m support in the fight for health equity

28-Jun-2022 By Jenni Spinner

The pharmaceutical company is expanding its alliance with historically Black medical schools to bolster the battle against systemic health disparities.

Intelligent eCOA use enhances trials, amplifies patient voice: Medable

28-Jun-2022 By Jenni Spinner

An expert from the decentralized trial solutions company shares how eCOA and ePRO can be useful tools that improve the collection and quality of such data.

Gates Foundation to fund pediatric brain research in low-income areas

28-Jun-2022 By Jenni Spinner

The Bill and Melinda Gates Foundation grant, awarded to data management platform Flywheel, will support pediatric brain development in impoverished areas.

Sanofi pushes to accelerate medical writing, reporting processes

27-Jun-2022 By Nick Taylor

The pharmaceutical company has enlisted the help of the AI and NLP tech specialist to streamline clinical study report generation and submission processes.

The Method rolls out experience for living as a Type 2 diabetes patient for a day

27-Jun-2022 By Nick Taylor

The company has added Type 2 diabetes to the list of conditions it simulates in it’s A Life in a Day program, enabling people to spend a day living as if they have the disease.

Janssen invests $5m in Stand Up To Cancer’s health equity effort

27-Jun-2022 By Jenni Spinner

The sponsorship from Janssen Pharmaceutical Companies will be used by the cancer support network to boost diversity in Phase I and Phase 2 clinical trials.

dia 2022

Greenphire talks clinical trial challenges at DIA Global Annual Meeting

23-Jun-2022 By Jenni Spinner

The trial financial management company outlined a range of solutions designed to help trial teams get a handle on budgeting, patient reimbursement, and more.

HistoSonics hits enrollment target en route to FDA filing for liver cancer therapy

22-Jun-2022 By Nick Taylor

The company reports it has met the enrollment target for a trial of its sonic beam therapy, one step closer to submitting for FDA approval of the product.

DIA 2022

Veeva app launched to simplify, automate clinical study training

22-Jun-2022 By Jenni Spinner

The company has introduced a mobile application designed to streamline and automate training in a single platform for sponsors, CROs, and research sites.

dia 2022

Javara, CVS Health join Parexel’s clinical trial alliance group

21-Jun-2022 By Jenni Spinner

Parexel's Community Alliance Network, designed to more deeply integrate clinical research into community healthcare, has invited Javara and CVS as members

DIA 2022

eCOA, eConsent solution elevates patient experience, data quality

21-Jun-2022 By Jenni Spinner

uMotif and ClinOne announced at the 2022 DIA Global Annual Meeting that they have partnered to deliver an integrated solution for eCOA and eConsent in trials

Survey: most people believe in need for more cancer research

21-Jun-2022 By Jenni Spinner

A new survey reveals the majority of the general public thinks more cancer research is in order, but many are reluctant to pitch in to the effort financially.